What’s happening to generic drug prices? December 2019 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw more price increases this past month, but an overall decrease in annualized spending based on typical utilization trends. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates on the latest generic drug price changes, plus an updated NADAC Packed Bubble Chart. Happy New Year.

Ben LinkDecember 31, 2019NADAC, Medicaid, Generic, Prograf, Tacrolimus, ADHD, Kapvay, Clonidine, Hyzaar, Losartan, Valsartan, Cozaar

What’s happening to generic drug prices? February 2019 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” It looks like we saw some very unfortunate generic inflation this past month. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for a lot of important updates, plus an updated and upgraded NADAC Packed Bubble Chart!

Ben LinkFebruary 24, 2019NADAC, Medicaid, Concerta, Methylphenidate, Diovan, Valsartan, Tetracycline, Valcyte, Valganciclovir, Frova, Frovatriptan, Endo

What’s happening to generic drug prices? October 2018 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our third installment of “what happened to generic drug prices last month.” It looks like there was a bit of net deflation, but overall, there were an equal number of price increases and decreases. But as always, the details matter. Check out our latest drug pricing report for a lot of important updates, plus an updated NADAC Packed Bubble Chart!